Rare diseases pose unique challenges in the medical field, often affecting a small but vulnerable population with limited treatment options. The Rare Disease Challenge (RaDiChal) is a groundbreaking ...

The Global Agtech and Advanced Food Technologies Market Report 2026-2036 reveals promising growth opportunities in vertical farming, smart farming, and alternative proteins, driven by population ...

In the first keynote session at the ACCC 2023 Annual Meeting and Cancer Center Business Summit, the history of CRISPR genome editing and its potential in cancer and other settings took center stage.

CRISPR's gene therapy, Casgevy, faces operational challenges and stiff competition from Lyfgenia, impacting its market adoption. The initial commercial rollout of gene therapies requires the ...

Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...

2023 was an important year for patients with sickle cell disease. Prior to CRISPR, the only cure for the life-long ailment was a bone marrow transplant, which is notoriously dangerous and costly. This ...

Menlo Ventures has made a $16 million bet that the “ baby KJ ” custom CRISPR therapy success story is repeatable. The funding ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

A new genome editing technology known as CRISPR has the potential to revolutionize the way scientists study diseases and genetics. “I think it’s a really useful tool for science, in fact it’s sort of ...

Professor of Biomedical Engineering, Head of Biomedical Engineering Programme, Director of CUHKSZ-Boyalife Joint Laboratory of Regenerative Medicine Engineering, Team Leader of Integrated Devices and ...

Kevin Davies, PhD, executive editor, The CRISPR Journal and GEN Biotechnology, and author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, discusses the difficulties ...